Loading clinical trials...

The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388) | Clinical Trials | Clareo Health

Back to search

COMPLETEDPHASE1

The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)

A Phase Ib Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Bronchodilatory Effect of MK0476 in Patients With Chronic Asthma

NCT00739297•Organon and Co

View on ClinicalTrials.gov

Summary

This study will test the safety and effectiveness of a range of doses of MK0476 (montelukast) compared to placebo on improved lung function in patients with chronic asthma.

Eligibility

Age

15 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•A person is 15 to 65 years of age. A person has had chronic asthma for at least one year

Exclusion Criteria

•A person is a smoker or has smoked more that a pack a day for more than 10 years before stopping
•A person has other lung disorders such as COPD (chronic obstructive pulmonary disorder)

Key Dates

Start Date

July 1, 2008

Primary Completion Date

December 1, 2008

Completion Date

December 1, 2008

Last Updated

May 9, 2024

Enrollment

ACTUAL participants

Conditions

Chronic Asthma

Interventions

Comparator: montelukast

DRUG

Comparator: placebo

DRUG

Intervention to Improve Inhalative Adherence

NCT02386722

Chronic AsthmaCOPD

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 9, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions